Top Markets
Coin of the day
Regnum Corp. Regnum Corp.

Regnum Corp.

RGMP
Rangering i aksjer #42305
Regnum Corp. is dedicated to advancing and marketing therapeutic agents... Regnum Corp. is dedicated to advancing and marketing therapeutic agents designed to combat both rare and infectious diseases. Its flagship product is Leronlimab (PRO 140), a monoclonal antibody functioning as a C-C chemokine receptor type 5 (CCR5) antagonist. This drug is specifically formulated to inhibit the human immunodeficiency virus (HIV) from gaining entry into human cells. Headquartered in New York, New York, Regnum Corp. operates as a subsidiary of Phoenixus AG.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$2.30K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Regnum Corp. (RGMP)

Kategori

Historikk for aksjesplitt for Regnum Corp. (RGMP)
Aksjen Regnum Corp. (symbol: RGMP) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 12, 2026.
Én RGMP-aksje kjøpt før Aug 12, 2026 tilsvarer i dag 0 RGMP-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR